ARTICLE | Clinical News
Elan to begin Phase IIa
July 23, 2001 7:00 AM UTC
ELN and partner American Home Products (AHP) will begin this quarter a 375-patient Phase IIa study of AN-1792 beta amyloid 42-amino acid peptide vaccine to treat mild-to-moderate Alzheimer's disease (...